CLCristian Camilo Cabrera Lugo

Cristian Camilo Cabrera Lugo

*This is an algorithmically generated author record based on publicly available information.

Cristian Camilo Cabrera Lugo has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Electrocardiogram-Based Deep Learning for Early and Silent Detection of Cardiomyopathies

    by José Enrique Gonzalez Araujo, Raphaela Ballon Chehade, Valentina Rodríguez Osorio, Cristóbal Washington Franco Lucas, Cristian Camilo Cabrera Lugo, Rubén Andrés Nisperuza Franco, César Augusto Rojas Landa, Francisco Javier Bautista Zarco

    Cardiomyopathies constitute a heterogeneous group of myocardial disorders that frequently remain clinically silent until advanced stages, limiting opportunities for early intervention and prevention of adverse outcomes. Although the 12-lead electrocardiogram (ECG) is one of the most accessible diagnostic tools in cardiovascular care, its conventional interpretation has limited sensitivity for detecting early or subclinical myocardial disease. In recent years, deep-learning approaches have enabled a paradigm shift in ECG analysis by allowing the extraction of complex and subtle signal patterns associated with underlying structural and functional cardiac abnormalities. This review synthesizes current evidence on deep-learning–based ECG algorithms for the silent detection of cardiomyopathies, with particular emphasis on hypertrophic cardiomyopathy and subclinical ventricular dysfunction. The analysis highlights methodological strategies, reference standards, and validation approaches used across key studies, as well as their potential clinical and educational implications. The findings suggest that deep-learning ECG analysis can function as an effective screening and risk-stratification tool, facilitating earlier identification of individuals who may benefit from confirmatory imaging and specialist evaluation. This approach is especially relevant for healthcare systems in Mexico, Colombia, and Ecuador, where access to advanced diagnostic resources may be limited. Continued research focusing on external validation, population-specific calibration, and real-world implementation is essential to ensure safe and effective integration into clinical practice.

  • Redefining Cardiovascular Risk: Integrative Approaches in Genomics, Inflammation, Imaging, and Artificial Intelligence

    by José Enrique González Araujo, Jhonatan Nieto Centeno, Francisco Xavier Chavez Molina, Cristian Camilo Cabrera Lugo, Sayuri Ibeth Ramos Meneses, Sebastián Felipe Peralta González, Edward Sebastian Ramos Maguiña, Cristian Alonso Duarte Carreño

    Cardiovascular risk stratification is undergoing a major paradigm shift driven by advances in genomics, inflammatory profiling, imaging biomarkers, myocardial injury detection, and artificial intelligence. This review integrates evidence from twenty high-impact studies to outline a multidimensional framework for precision cardiovascular risk assessment. Genomic tools, particularly polygenic risk scores, consistently demonstrate strong predictive value and highlight substantial inherited susceptibility that traditional models often fail to detect. Inflammatory and immunometabolic markers emerge as equally central determinants, underscoring the biological complexity of atherosclerosis and the relevance of chronic immune activation. Imaging techniques and high-sensitivity biomarkers provide additional layers of subclinical resolution, while AI-enhanced electrocardiography introduces new opportunities for early detection. A temporal analysis reveals a rapid expansion of precision-oriented research after 2018, culminating in a robust evidence base that favors integrative models over single-domain predictors. The proposed conceptual framework illustrates how these domains converge to generate a richer, individualized understanding of cardiovascular risk. The discussion emphasizes translational challenges and the need for equitable implementation in diverse populations, particularly in Mexico, Colombia, and Ecuador, where structural barriers may limit access to emerging precision tools. Overall, the findings support a shift toward biologically informed, technologically augmented, and context-adapted cardiovascular prevention strategies capable of improving predictive accuracy and advancing global cardiovascular health.